Compare · CNC vs OMI
CNC vs OMI
Side-by-side comparison of Centene Corporation (CNC) and Owens & Minor Inc. (OMI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CNC and OMI operate in Medical Specialities (Health Care), so they compete in similar markets.
- CNC is the larger of the two at $31.31B, about 9.6x OMI ($3.27B).
- Over the past year, CNC is up 136.0% and OMI is down 64.4% - CNC leads by 200.5 points.
- CNC has hit the wire 3 times in the past 4 weeks while OMI has been quiet.
- CNC has more recent analyst coverage (25 ratings vs 12 for OMI).
- Company
- Centene Corporation
- Owens & Minor Inc.
- Price
- $63.40-0.51%
- $2.79+1.82%
- Market cap
- $31.31B
- $3.27B
- 1M return
- +0.69%
- +4.68%
- 1Y return
- +136.02%
- -64.44%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 3
- 0
- Recent ratings
- 25
- 12
Centene Corporation
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members in the Managed Care segment. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; and vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Owens & Minor Inc.
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels. This segments products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. The company provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is headquartered in Richmond, Virginia.
Latest CNC
- Director Tyler Lauren M was granted 3,155 shares, increasing direct ownership by 5,172% to 3,216 units (SEC Form 4)
- CENTENE CORPORATION TO HOST 2026 SECOND QUARTER FINANCIAL RESULTS EARNINGS CALL
- CENTENE SUBSIDIARY MERIDIAN HEALTH PLAN OF ILLINOIS AWARDED ILLINOIS MEDICAID CONTRACT
- Director Tyler Lauren M was granted 61 shares (SEC Form 4)
- Director Samuels Theodore R. Ii was granted 465 shares, increasing direct ownership by 2% to 25,213 units (SEC Form 4)
- Director Tanji Kenneth was granted 581 shares, increasing direct ownership by 5% to 12,490 units (SEC Form 4)
- Director Eppinger Frederick H was granted 833 shares, increasing direct ownership by 0.23% to 369,538 units (SEC Form 4)
- Director Coughlin Christopher J was granted 562 shares, increasing direct ownership by 3% to 18,711 units (SEC Form 4)
- Health Net Providing Special Assistance to Members and Providers Affected by Palos Warehouse Fire in Los Angeles
- RBC Capital Mkts initiated coverage on Centene with a new price target
Latest OMI
- Amendment: Owens & Minor Inc. filed SEC Form 8-K: Financial Statements and Exhibits
- Owens & Minor Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure
- Owens & Minor, Inc. Completes Sale of Products & Healthcare Services Business to Platinum Equity
- Owens & Minor Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure
- Owens & Minor Announces Corporate Name Change to Accendra Health, Inc.
- Owens & Minor Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Owens & Minor Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Owens & Minor to Present at Upcoming Investor Conferences on December 2, 2025
- EVP, CEO P&HS Long Andrew G gifted 47,908 shares, decreasing direct ownership by 18% to 214,064 units (SEC Form 4)
- Owens & Minor downgraded by UBS with a new price target